Companies/SynAct Pharma AB
Follow

SynAct Pharma AB

SynAct Pharma is a pharmaceutical group that conducts research and development in the treatment of inflammatory diseases. The company has developed a platform technology that is aimed at severe conditions in chronic inflammatory diseases, and foremost joint injuries.

Sector:
HEALTH CARE
Media
Showing 3 of 8
View all
www.synactpharma.se
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
SYNACT
SE0008241491
Details of share in SynAct Pharma AB with ticker SYNACT
Status
Active
Amount of instruments
26 006 295
Currency
SEK
First trading date
11 Jul 2016
Exercise
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
SYNACT
SE0008241491
Details of share in SynAct Pharma AB with ticker SYNACT
Status
Active
Amount of instruments
26 006 295
Currency
SEK
First trading date
11 Jul 2016
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SYNACT TO1
SE0008320972
Spotlight Stock Market
Sweden (SE)
Details of option in SynAct Pharma AB with ticker SYNACT TO1
Status
Archived
Amount of instruments
2 020 000
Currency
SEK
Trading period
11 Jul 2016 - 21 Mar 2017
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 6.4.
Update (09.03.2017): Starts of subscription period for warrants TO1.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SYNACT TO2
SE0013409620
Spotlight Stock Market
Sweden (SE)
Details of option in SynAct Pharma AB with ticker SYNACT TO2
Status
Archived
Amount of instruments
4 891 268
Currency
SEK
Trading period
20 Jan 2020 - 20 Jul 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 6.70.
Exercise
Sign in to buy
People
Jeppe Øvlesen
CEO
Torbjørn Bjerke
Chairman of the board
John Haurum
Board member
Marina Bozilenko
Board member
Terje Kalland
Board member
Thomas Jonassen
Board member
Uli Hacksell
Board member
Kerstin Hasselgren
Board member
Company Details
Sector
HEALTH CARE
Website
Address
C/O Medicon Village Ab
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559058-4826
LEI code
549300RRYIEFEQ72N546
First trade date
11 Jul 2016
Registration date
12 Apr 2016
Short name
SYNACT

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More